These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 28397672

  • 21. Performance of idarucizumab as antidote of dabigatran in daily clinical practice.
    van der Wall SJ, van Rein N, van den Bemt B, Kruip MJHA, Meijer K, Te Boome LCJ, Simmers TA, Alings AMW, Tieleman R, Klok FA, Huisman MV, Westerweel PE.
    Europace; 2019 Mar 01; 21(3):414-420. PubMed ID: 30339226
    [Abstract] [Full Text] [Related]

  • 22. Idarucizumab for dabigatran overdose in a child.
    Shapiro S, Bhatnagar N, Khan A, Beavis J, Keeling D.
    Br J Haematol; 2018 Feb 01; 180(3):457-459. PubMed ID: 27734469
    [No Abstract] [Full Text] [Related]

  • 23. Idarucizumab for Reversing Dabigatran-Induced Anticoagulation: A Systematic Review.
    Thibault N, Morrill AM, Willett KC.
    Am J Ther; 2018 Feb 01; 25(3):e333-e338. PubMed ID: 27175894
    [Abstract] [Full Text] [Related]

  • 24. The Antidote Is Finally Here! Idarucizumab, A Specific Reversal Agent for the Anticoagulant Effects of Dabigatran.
    O'Malley PA.
    Clin Nurse Spec; 2016 Feb 01; 30(2):81-3; quiz E9. PubMed ID: 26848896
    [No Abstract] [Full Text] [Related]

  • 25. [Treatment with inhibitors of new oral direct anticoagulants in patients with severe bleedings or urgent surgical procedures. The new dabigatran antidote: the place of idarucizumab in clinical practice].
    Boda Z.
    Orv Hetil; 2016 Mar 20; 157(12):443-50. PubMed ID: 26971644
    [Abstract] [Full Text] [Related]

  • 26. Emergency LP in a patient receiving dabigatran after antagonization with idarucizumab.
    Braemswig TB, Eschenfelder CC, Nolte CH.
    Am J Emerg Med; 2017 Apr 20; 35(4):662.e3-662.e4. PubMed ID: 27836320
    [Abstract] [Full Text] [Related]

  • 27. Idarucizumab, a Humanized, Monoclonal Antibody Fragment for Immediate Reversal of Dabigatran.
    Miyares MA, Kuyumjian Y, Eaves S, Dollard E.
    J Pharm Pract; 2015 Dec 20; 28(6):548-54. PubMed ID: 26894245
    [Abstract] [Full Text] [Related]

  • 28. Dabigatran Reversal in a Patient With End-Stage Liver Disease and Acute Kidney Injury.
    Novak JE, Alamiri K, Yee J.
    Am J Kidney Dis; 2018 Jan 20; 71(1):137-141. PubMed ID: 28549534
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Real-World Experience with Idarucizumab to Reverse Anticoagulant Effect in Dabigatran-Treated Patients: Report of 11 Cases from Taiwan.
    Tsai LK, Lin HJ, Chua SK, Liao PC, Yang YP, Chou PC, Lee CW, Lin MJ, Chen HM, Yeh JT, Li YH.
    J Stroke Cerebrovasc Dis; 2018 Feb 20; 27(2):e27-e33. PubMed ID: 29122465
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Persistent life-threatening hemorrhage after administration of idarucizumab.
    Alhashem HM, Avendano C, Hayes BD, Winters ME.
    Am J Emerg Med; 2017 Jan 20; 35(1):193.e3-193.e5. PubMed ID: 27439386
    [No Abstract] [Full Text] [Related]

  • 35. Probable drug-drug interaction between dabigatran and quinidine resulting in thrombin time rebound despite multiple idarucizumab doses.
    George S, Taburyanskaya M, Lewis V.
    Blood Coagul Fibrinolysis; 2019 Jan 20; 30(1):42-46. PubMed ID: 30431448
    [Abstract] [Full Text] [Related]

  • 36. Idarucizumab for Reversal of Dabigatran in Early/Emergency Surgeries: A Case Series.
    Peacock WF, Grotta JC, Steiner T.
    J Emerg Med; 2019 Dec 20; 57(6):e167-e173. PubMed ID: 31662218
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Reversal of dabigatran requiring hemodialysis, fresh frozen plasma, and 2 doses of idarucizumab in a patient with acute kidney injury.
    Sheikh-Taha M.
    Am J Health Syst Pharm; 2019 Jan 01; 76(1):9-12. PubMed ID: 31381100
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Assessment of patients post reversal with idarucizumab.
    Raco V, Ahuja T, Green D.
    J Thromb Thrombolysis; 2018 Nov 01; 46(4):466-472. PubMed ID: 30120649
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.